4Basebio PLC (4BB)

ORD EUR1.00

Sell: 720.00p|Buy: 800.00p|Change: 2.44 (0.32%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Open

760.00p

Previous close

760.00p

Trade high

800.00p

Volume

Year high

1,500.00p

Year low

704.50p

Dividend yield

–

Market capitalisation

£118.06 mn

P/E ratio

–

ISIN

GB00BMCLYF79

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Share price

Performance 15/10/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
4Basebio PLC	0.00
FTSE AIM All Share	+ 0.33
More...

Company profile

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
17/10/2025	11:24:03	762.44	1	7.62
17/10/2025	10:23:00	800	1	8.00
17/10/2025	08:30:19	724	21	152.04
16/10/2025	02:04:10	724	10	72.40
15/10/2025	01:45:07	762.44	1	7.62

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.